Vicente Anido, Jr.
2019
In 2019, Vicente Anido, Jr. earned a total compensation of $5.5M as Chief Executive Officer and Chairman of the Board at Aerie Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $362,303 |
|---|---|
| Option Awards | $3,300,325 |
| Salary | $772,500 |
| Stock Awards | $1,094,538 |
| Total | $5,529,666 |
Anido received $3.3M in option awards, accounting for 60% of the total pay in 2019.
Anido also received $362.3K in non-equity incentive plan, $772.5K in salary and $1.1M in stock awards.
Rankings
In 2019, Vicente Anido, Jr.'s compensation ranked 1,916th out of 13,971 executives tracked by ExecPay. In other words, Anido earned more than 86.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,916 out of 13,971 | 86th |
Division Manufacturing | 694 out of 5,692 | 88th |
Major group Chemicals And Allied Products | 213 out of 2,189 | 90th |
Industry group Drugs | 170 out of 1,875 | 91st |
Industry Biological Products, Except Diagnostic Substances | 40 out of 389 | 90th |
Source: SEC filing on April 24, 2020.
Anido's colleagues
We found five more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2019.
2019
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2019
John LaRocca
Aerie Pharmaceuticals
General Counsel
2019
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2019
David Hollander
Aerie Pharmaceuticals
Chief Research and Development Officer
2019
Casey Kopczynski
Aerie Pharmaceuticals
Chief Scientific Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019